The Science and Technology Committee's new inquiry into the future of Innovate UK hears evidence from industry figure representatives and from academics.
Purpose of the session
For its latest inquiry the Committee examines the implications of the Government’s newly announced plans to incorporate Innovate UK into UK Research and Innovation alongside the Research Councils and Research England.
Tuesday 7 June in Committee Room 4A, Palace of Westminster
- David Eyton, Group Head of Technology, BP
- Dr Virginia Acha, Executive Director of Research, Medical & Innovation, Association of the British Pharmaceutical Industry (ABPI)
- Laura Smith, Head of Construction & Manufacturing, CBI (Confederation of British Industry)
- Professor Luke Georghiou, Vice President Research and Innovation, University of Manchester
- Dr David Hardman MBE, Chairman, United Kingdom Science Park Association
Areas of discussion
The evidence sessions cover areas such as:
- The impact of Innovate UK to date
- Challenges and barriers faced by businesses working with Innovate UK
- The risks and opportunities of the Government’s proposals
- How Innovate UK works in the regions